Cargando…
GPCR Modulation of Thieno[2,3-b]pyridine Anti-Proliferative Agents
A panel of docking scaffolds was developed for the known molecular targets of the anticancer agents, thieno[2,3-b]pyridines, in order to glean insight into their mechanism of action. The reported targets are the copper-trafficking antioxidant 1 protein, tyrosyl DNA phosphodiesterase 1, the colchicin...
Autores principales: | Zafar, Ayesha, Sari, Suat, Leung, Euphemia, Pilkington, Lisa I., van Rensburg, Michelle, Barker, David, Reynisson, Jóhannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149898/ https://www.ncbi.nlm.nih.gov/pubmed/29258235 http://dx.doi.org/10.3390/molecules22122254 |
Ejemplares similares
-
Investigation into Improving the Aqueous Solubility of the Thieno[2,3-b]pyridine Anti-Proliferative Agents
por: Zafar, Ayesha, et al.
Publicado: (2018) -
Disruption of Crystal Packing in Thieno[2,3-b]pyridines Improves Anti-Proliferative Activity
por: Haverkate, Natalie A., et al.
Publicado: (2022) -
Tethered Aryl Groups Increase the Activity of Anti-Proliferative Thieno[2,3-b]Pyridines by Targeting a Lipophilic Region in the Active Site of PI-PLC
por: Haverkate, Natalie A., et al.
Publicado: (2021) -
Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compound
por: Mastelić, Angela, et al.
Publicado: (2017) -
Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative
por: Reynisson, Jóhannes, et al.
Publicado: (2016)